SCHEMBL739839

SCHEMBL739839

COc1ccc(C(=O)Nc2n[nH]c3sc(C(=O)NC4(c5ccccc5)CC4)cc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.44
ADORA3 P0DMS8 3/20 0.42
CDK7 P50613 1/20 0.42
ADORA1 P30542 1/20 0.42
ROCK2 O75116 2/20 0.41
ROCK1 Q13464 2/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNA1 P78396 2/20 0.41
AURKA O14965 1/20 0.41
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40
FLT3 P36888 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739951 0.90 PDE2A (0.47) HDAC6NPC1RAB9A
SCHEMBL741934 0.88 HSD17B13 (0.42) HDAC6CDK7ROCK2CCNA2CDK2
SCHEMBL742601 0.85 KIT (0.53) CCNA2CDK2CCNA1AURKAFLT3
SCHEMBL741273 0.85 HSD17B13 (0.40) HDAC6CDK7ROCK2ROCK1CCNA2
SCHEMBL2421114 0.84 KCNK9 (0.53) HDAC6ADORA3CDK7ROCK2ROCK1
SCHEMBL741208 0.84 AURKA (0.57) AURKAFLT3KIT
SCHEMBL742597 0.83 AURKA (0.53) ROCK1AURKAFLT3KDRKIT
SCHEMBL4632621 0.83 HDAC6 (0.53) HDAC6ADORA3CDK7CCNA2CDK2
SCHEMBL739470 0.82 FLT3 (0.47) HDAC6AURKAFLT3KDRKIT
SCHEMBL2418809 0.82 RAB9A (0.57) HDAC6ADORA3CDK7CDK2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed